Data from the ORBITA-2 randomized, placebo-controlled trial emphasize that patient age alone should not be the deciding factor for undergoing symptom-relieving therapies.

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...

In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...

Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...

A statewide effort to get hospitals in Michigan to lower their procedural radiation levels for PCI resulted in a steady decrease over a 6-year period, new data show. “We were really pleased to see ...

TCT 514: Safety and Efficacy of 19 different Stent Strategies in Percutaneous Coronary Intervention. A Trial-Sequential, Influential, Bivariate and Network Meta-Analysis Receive the the latest news, ...

Patients who suffer a GI bleed after PCI are a challenging group. They may have multiple comorbidities and are often medically unstable; treatment must balance the need to prevent ischemic ...